Muammar Fawwaz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

High Resolution

Single Molecule

Epidermal Growth Factor Receptor

Top Venues

BioImpacts : BI

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Universitas Muslim Indonesia

Universitas Hasanuddin (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitas Muslim Indonesia Jun 05 2012

Indonesia

Lecturer and Researcher :: Pharmacy

Education History

Universitas Hasanuddin

Indonesia

MSC :: Pharmacy

Publications

Muammar Fawwaz, Kenji Mishiro, Arwansyah Arwansyah, Ryuichi Nishii, Kazuma Ogawa
Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer. BioImpacts : BI 14 (1) (2023)
Muammar Fawwaz, Kenji Mishiro, Arwansyah Arwansyah, Ryuichi Nishii, Kazuma Ogawa
Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer. BioImpacts : BI 14 (1) (2023)
Muammar Fawwaz, Kenji Mishiro, Ryuichi Nishii, Akira Makino, Yasushi Kiyono, Kazuhiro Shiba, Seigo Kinuya, Kazuma Ogawa
A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Muammar Fawwaz, Kenji Mishiro, Ryuichi Nishii, Izumi Sawazaki, Kazuhiro Shiba, Seigo Kinuya, Kazuma Ogawa
Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR). Molecules (Basel, Switzerland) 25 (12) (2020)